A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial): Initial U.S. Experience - Dixon, SR; Henriques, JPS; Mauri, L (JACC Cardiovasc Interv, 2009)
et al.